Analyst
Rare Disease Business Leader
Analyst
Rare Diseases
Analyst
Chief of Rare Diseases
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Marc Dunoyer is recorded as Analyst at Rare Disease Business Leader, Analyst at Rare Diseases, Analyst at Chief of Rare Diseases and CEO at Astrazeneca PLC (AZN). Marc Dunoyer has spoken on 1 earnings call across 1 company, most recently for Astrazeneca PLC on March 31, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Rare Disease Business Leader
Analyst
Source not stated
Rare Diseases
Analyst
Source not stated
Chief of Rare Diseases
Analyst
Source not stated
Recorded roles and call appearances connecting this person to public companies.
AZN
CEO
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
